← Back to Conditions

Burkitt's lymphoma (clinical)

disorder
SNOMED 118617000CUI C0006413

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Research Evidence

Peer-reviewed studies linked via MeSH term "Burkitt Lymphoma" from the MEDLINE/PubMed database.

Sort:
Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review.
[object Object], [object Object], [object Object] et al. · Cancer Med · 2025
PMID: 39878399Meta-AnalysisFull text (PMC)
Emergency laparotomy for abdominal catastrophes secondary to lymphoma: A systematic review.
[object Object], [object Object], [object Object] et al. · Eur J Surg Oncol · 2024
PMID: 38043361Meta-Analysis
Mosquito Bed Net Use and Burkitt Lymphoma Incidence in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
[object Object], [object Object], [object Object] · JAMA Netw Open · 2024
PMID: 38635267Meta-AnalysisFull text (PMC)
Impact of age on efficacy and safety of chimeric antigen receptor-T in B-cell acute lymphoblastic leukaemia-A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Br J Haematol · 2023
PMID: 37814795Meta-Analysis
EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW.
[object Object], [object Object], [object Object] et al. · Exp Oncol · 2022
PMID: 36325697Meta-Analysis
Estimating the global burden of Epstein-Barr virus-related cancers.
[object Object], [object Object], [object Object] et al. · J Cancer Res Clin Oncol · 2022
PMID: 34705104Meta-AnalysisFull text (PMC)
Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia.
[object Object], [object Object], [object Object] et al. · Blood Adv · 2022
PMID: 34610109Meta-AnalysisFull text (PMC)
Malaria Infection and Risk for Endemic Burkitt Lymphoma: A Systematic Review and Meta-Analysis.
[object Object], [object Object] · Int J Environ Res Public Health · 2021
PMID: 34070881Meta-AnalysisFull text (PMC)
Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies.
[object Object], [object Object], [object Object] et al. · Clin Lymphoma Myeloma Leuk · 2021
PMID: 33947633Meta-Analysis

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Anomaly of the bone marrow cells
Frequent (30-79%)HP:0005561
Hyperuricaemia
Frequent (30-79%)HP:0002149
Increased lactate dehydrogenase level
Frequent (30-79%)HP:0025435
Lesion of oral cavity
Frequent (30-79%)HP:0100649
Abnormal lymph node histology
Occasional (5-29%)HP:0002733
Abnormality of the pancreas
Occasional (5-29%)HP:0001732
Abnormality of the spleen
Occasional (5-29%)HP:0001743
Bowel obstruction
Occasional (5-29%)HP:0005214
Decreased proportion of CD4-positive T cells
Occasional (5-29%)HP:0032218
Gastro pain
Occasional (5-29%)HP:0002027
Gastrointestinal haemorrhage
Occasional (5-29%)HP:0002239
Liver disease
Occasional (5-29%)HP:0001392
Nausea and vomiting
Occasional (5-29%)HP:0002017
Ovarian disease
Occasional (5-29%)HP:0000137
Burkitt lymphoma
HP:0030080
Immune deficiency
HP:0002721

Quick Facts

SNOMED CT
118617000
UMLS CUI
C0006413
Fully Specified Name
Burkitt's lymphoma (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
16
Known Treatments
3
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.